BRAF mutations are the defining molecular alteration that links double mutant BRAF/PIK3CA colorectal cancers with MSI, a higher TMB, high CIMP, and low CIN, given that cancers with BRAF mutant/PIK3CA wild type cancers have similar rates of these characteristics without statistically significant differences compared to double mutants. This evidence concerns the gene BRAF and colorectal cancer.